Magnetic nanoparticles for "smart liposomes"

Eur Biophys J. 2015 Dec;44(8):647-54. doi: 10.1007/s00249-015-1059-0. Epub 2015 Jul 17.

Abstract

Liposomal drug delivery systems (LDDSs) are promising tools used for the treatment of diseases where highly toxic pharmacological agents are administered. Currently, destabilising LDDSs by a specific stimulus at a target site remains a major challenge. The bacterial mechanosensitive channel of large conductance (MscL) presents an excellent candidate biomolecule that could be employed as a remotely controlled pore-forming nanovalve for triggered drug release from LDDSs. In this study, we developed superparamagnetic nanoparticles for activation of the MscL nanovalves by magnetic field. Synthesised CoFe2O4 nanoparticles with the radius less than 10 nm were labelled by SH groups for attachment to MscL. Activation of MscL by magnetic field with the nanoparticles attached was examined by the patch clamp technique showing that the number of activated channels under ramp pressure increased upon application of the magnetic field. In addition, we have not observed any cytotoxicity of the nanoparticles in human cultured cells. Our study suggests the possibility of using magnetic nanoparticles as a specific trigger for activation of MscL nanovalves for drug release in LDDSs.

Keywords: CoFe2O4; Drug delivery system; Liposomes; Magnetic nanoparticles; Mechanosensitive channels; MscL; Patch clamp.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Cell Line, Tumor
  • Cobalt / chemistry
  • Escherichia coli Proteins / chemistry*
  • Ferric Compounds / chemistry
  • Humans
  • Ion Channels / chemistry*
  • Liposomes / chemistry*
  • Magnetic Fields
  • Magnetite Nanoparticles / adverse effects
  • Magnetite Nanoparticles / chemistry*

Substances

  • Escherichia coli Proteins
  • Ferric Compounds
  • Ion Channels
  • Liposomes
  • Magnetite Nanoparticles
  • MscL protein, E coli
  • cobalt ferrite
  • Cobalt